LINDT LES GRANDES MILK HAZELNUT

WhatsApp Order
Lindt LES GRANDES Milk Hazelnut is a premium milk chocolate bar from Lindt’s luxury Les Grandes line, containing 35% cocoa solids and 34% hazelnuts in the form of whole roasted hazelnuts and crunchy caramelised hazelnut pieces. A 30 g serving (2 squares) provides approximately 175 kcal, 13 g fat, 12 g sugar, 3 g protein, and 1.5 g fibre. For the dietitian and geriatrician, this product offers concentrated calories for cachectic patients, plant protein and fibre for frail elderly patients, and mood enhancement for palliative care and dementia settings. The sweet, creamy milk chocolate is highly palatable and helps mask metallic dysgeusia in chemotherapy and renal patients. However, whole and crunchy hazelnut pieces pose a significant choking hazard – this product is not suitable for patients with oropharyngeal dysphagia, poor dentition, cognitive impairment, or anyone requiring texture‑modified diets. Contains hazelnuts (tree nuts), milk, and soya. For appropriate patients without swallowing or allergy concerns, a few squares deliver indulgent pleasure with meaningful nutritional and sensory benefits.
Description

LINDT LES GRANDES MILK HAZELNUT

PRIMARY CLINICAL & DIAGNOSTIC USES

1. High-Density Calorie Supplement for Patients with Unintentional Weight Loss or Cachexia
  • Primary Use: Provides an energy-dense milk chocolate bar (approximately 585 kcal per 100 g) containing 34% whole roasted hazelnuts and caramelised hazelnut pieces, designed to supplement oral intake in patients with cancer cachexia, advanced COPD, heart failure, or dementia-related anorexia who require calorie-dense, low-volume nutrition.
  • How it helps: For the dietitian, geriatrician, and palliative care physician, each 30 g serving (2 squares) provides approximately 175 kcal, 13 g fat (including heart‑healthy monounsaturated fats from hazelnuts), 12 g sugar, 3 g protein, and 1.5 g fibre. The creamy milk chocolate (35% cocoa solids) with whole roasted hazelnuts is highly palatable and requires minimal chewing. For the patient, a few squares help maintain weight without feeling overly full, turning a nutritional need into an enjoyable treat.
2. Plant Protein and Dietary Fibre for Malnourished or Frail Elderly Patients
  • Primary Use: The hazelnut component contributes plant-based protein (approximately 2.8 g per serving) and dietary fibre (approximately 1.5 g per serving), complementing the energy density of milk chocolate, making this product suitable for frail elderly patients with sarcopenia, poor appetite, or those requiring increased protein and fibre intake without large food volumes.
  • How it helps: For the geriatrician and dietitian, hazelnuts provide approximately 8 g of protein per 100 g, plus fibre, vitamin E (antioxidant), and magnesium. A 30 g serving provides a meaningful contribution to daily protein and fibre goals, supporting muscle maintenance and digestive regularity. For the patient, a small, enjoyable treat can support strength and comfort.
3. Mood Enhancement and Sensory Stimulation in Palliative Care, Dementia, and Depression
  • Primary Use: Used as a small, comforting treat to elevate mood, provide multi-textural sensory stimulation (smooth milk chocolate, crunchy whole hazelnuts, crisp caramelised pieces), and evoke positive memories in patients receiving palliative care, those with mild to moderate depression, or individuals with dementia.
  • How it helps: For the palliative care physician, hospice nurse, and occupational therapist, the combination of creamy sweet chocolate and crunchy nuts engages multiple senses, improves alertness, and can trigger positive autobiographical memories. Milk chocolate triggers endorphin and serotonin release more readily than dark chocolate due to its higher sugar and fat content. The act of chewing hazelnuts provides proprioceptive and oral motor stimulation. For the patient, a small piece can bring a moment of joy and connection during a difficult illness trajectory.
4. Masking of Unpleasant Tastes (Dysgeusia) in Chemotherapy and Renal Patients
  • Primary Use: The sweet, creamy milk chocolate combined with rich hazelnut flavour effectively masks metallic, bitter, or ammonia‑like tastes reported by patients undergoing chemotherapy, haemodialysis, or those with advanced liver disease, thereby encouraging oral intake when other foods are refused.
  • How it helps: For the oncology dietitian and nephrologist, the strong, pleasant nutty flavour of hazelnut can overpower distorted taste perceptions better than plain chocolate. One or two squares consumed slowly before a meal can help reset the palate. The sweetness of milk chocolate is often better tolerated than the bitterness of dark chocolate by patients with severe taste changes. For the patient, this can reduce meal‑related aversion and support nutritional intake during treatment.

SECONDARY USES

1. Small, portion‑controlled treat for patients with diabetes (in moderation): A 30 g serving (2 squares) contains 12 g sugar. The fibre and fat from hazelnuts help slow gastric emptying and attenuate the glycaemic response compared to plain milk chocolate. Can be incorporated into a diabetic meal plan as an occasional treat, with careful carbohydrate counting.
2. Source of magnesium for patients with muscle cramps or mild deficiency: Hazelnuts are rich in magnesium (approximately 160 mg per 100 g). A 30 g serving provides a small contribution to daily requirements, potentially helping reduce nocturnal leg cramps.
3. Non‑medical comfort for needle phobia or distressing procedures: Offering a square of LES GRANDES Milk Hazelnut as a reward or distraction during venepuncture, cannulation, or vaccinations can reduce anxiety, with the sweet flavour and crunchy texture providing sensory focus.
4. Long shelf‑life, portable snack for homebound or low‑resource patients: Individually packaged 150 g bars have a shelf life of approximately 364 days, making them a practical non‑perishable energy reserve for patients with limited access to fresh snacks.
5. Reward to improve adherence to oral nutritional supplements (ONS): For patients who refuse or struggle to consume prescribed oral nutritional supplements, a small piece offered as positive reinforcement can improve long‑term adherence.
6. Alternative for patients who find dark chocolate too bitter: With 35% cocoa solids and added milk, this bar is sweet, creamy, and mild – suitable for patients, particularly children or older adults, who dislike the bitterness of dark chocolate.
KEY PRODUCT FEATURES

1. BASIC IDENTIFICATION ATTRIBUTES

  • Device Type: Solid milk chocolate bar with whole roasted hazelnuts and caramelised hazelnut pieces.
  • Designation: Lindt LES GRANDES Milk Hazelnut, Lindt Les Grandes Milk Chocolate with Hazelnut.
  • Key Components: Sugar, hazelnuts (34%) (whole and ground), cocoa butter, whole milk powder, cocoa mass, caramelised hazelnuts (7%) [hazelnuts (70%), sugar], skimmed milk powder, emulsifier (soya lecithin), barley malt extract, natural vanilla flavouring.
  • Cocoa Solids: 35% minimum.
  • Milk Solids: 18% minimum.
  • Hazelnut Content: 34% of total weight.

2. TECHNICAL & PERFORMANCE PROPERTIES

  • Physical Form: Solid bar (breakable squares) with visible whole roasted hazelnuts and smaller caramelised hazelnut pieces.
  • Flavour Profile: Sweet, creamy milk chocolate with rich, roasted, nutty notes from hazelnuts and sweet, crunchy caramelised pieces.
  • Texture: Variable – smooth, creamy milk chocolate matrix with firm, crunchy whole hazelnuts and crispy, sweet caramelised pieces.
  • Energy Density: Approximately 585 kcal per 100 g; 175 kcal per 30 g serving (2 squares).
  • Fat Content: 43 g per 100 g (saturated 21 g).
  • Carbohydrate Content: 44 g per 100 g (sugars 41 g).
  • Protein Content: 9 g per 100 g; 2.7 g per 30 g serving.
  • Fibre Content: Approximately 5 g per 100 g.
  • Shelf Life (unopened): Approximately 364 days when stored at 14‑18°C (57‑64°F).
  • Packaging: Foil‑wrapped bar inside outer packaging. Standard size: 150 g.
  • Allergen Information: Contains hazelnuts (tree nuts), milk, soya, and barley (gluten). Not suitable for patients with tree nut allergy, cow's milk protein allergy, soya allergy, or coeliac disease/gluten sensitivity.

3. PHYSICAL & OPERATIONAL PROPERTIES

  • Preparation: No preparation required. Break into squares. Serve at room temperature (18‑20°C).
  • Usage Instructions: Unwrap and enjoy. Chew carefully due to whole hazelnuts and crunchy pieces. Not suitable for patients with dysphagia, poor dentition, cognitive impairment, or anyone requiring texture‑modified diets.
  • Storage Conditions: Store in a cool (14‑18°C), dry, dark place, away from strong odours. Avoid temperature fluctuations to prevent chocolate bloom.
  • Portion Size: 15‑30 g (1‑2 squares) per day as an occasional treat.

4. SAFETY & COMPLIANCE ATTRIBUTES

  • Allergens: Contains hazelnuts, milk, soya, barley (gluten). Contraindicated in patients with tree nut allergy, cow's milk protein allergy, soya allergy, or coeliac disease. May contain other tree nuts.
  • Nutritional Caution: High in sugar (41 g per 100 g) and saturated fat (21 g per 100 g). Patients with diabetes, hypertriglyceridemia, obesity, or hypercholesterolaemia should use sparingly.
  • Choking Hazard: Whole hazelnuts and crunchy pieces pose a significant risk of airway obstruction. Contraindicated in patients with oropharyngeal dysphagia, following stroke, with Parkinson's disease, advanced dementia, poor dentition, or any condition requiring texture‑modified diets.
  • Quality Assurance: Manufactured under GMP and HACCP in Switzerland.

5. STORAGE & HANDLING ATTRIBUTES

  • Storage: Keep unopened in a cool, dark cupboard (14‑18°C). Avoid temperature fluctuations.
  • Shelf Life: Refer to "best before" date on package (approx. 364 days).
  • Usage: Remove wrapper before serving. Do not give to patients with swallowing difficulties or young children.
  • Inspection: Discard if mould, rancid odour, or significant colour change (green/grey) is observed. Rancid hazelnuts have a bitter, paint‑like smell. White surface bloom is harmless.
SAFETY HANDLING PRECAUTIONS

1. SAFETY PRECAUTIONS

Choking hazard – contraindicated in dysphagia, poor dentition, cognitive impairment: Whole hazelnuts and crunchy caramelised pieces can cause airway obstruction. Do not use in patients with oropharyngeal dysphagia, after stroke, with Parkinson's disease, advanced dementia, poor dentition, or anyone requiring texture‑modified diets (IDDSI Levels 0‑5). For patients cleared for solid crunchy foods, extreme caution (supervision, small pieces, careful chewing) is required.
Tree nut allergy – contraindicated: Contains hazelnuts (34% of product weight). Patients with confirmed tree nut allergy (including hazelnut) must avoid. Cross‑contamination with other nuts is possible.
Milk allergy – contraindicated: Contains whole and skimmed milk powder. Patients with cow's milk protein allergy must avoid.
Soya allergy – contraindicated: Contains soya lecithin.
Gluten/coeliac – contraindicated: Contains barley malt extract. Not suitable for patients with coeliac disease or gluten sensitivity.
Sugar content – monitor in diabetes: 30 g serving contains 12 g sugar. Account in carbohydrate counting.
Saturated fat – caution in hypercholesterolaemia: 30 g serving contains approximately 6.5 g saturated fat.
Dental caries risk – high sugar and sticky texture: Advise brushing or rinsing after consumption. Hazelnut pieces may lodge between teeth.
Dental damage – hard hazelnuts may fracture teeth: Patients with fragile teeth or dental restorations should avoid or exercise extreme caution.
Theobromine content – lower than dark chocolate but present: Excessive consumption (>75 g daily) may cause nausea, headache, palpitations in sensitive individuals.
Migraine trigger – avoid in patients with known chocolate or nut sensitivity.
Pet toxicity – keep away from animals: Milk chocolate and hazelnuts are harmful to dogs and cats.
Infant and toddler safety – not suitable for children under 3 years: Choking hazard, high sugar, and theobromine.
Training requirement: Assess swallowing, dental, and allergy status before recommending. Educate on portion control, choking risk, and allergen awareness.

2. FIRST AID MEASURES

Choking: Standard back blows and abdominal thrusts. Call emergency services if obstruction persists.
Ingestion of large quantity (50‑75 g): May cause nausea, vomiting, abdominal pain, diarrhoea, headache, palpitations. Large amounts of hazelnuts may cause gastrointestinal obstruction. Seek medical attention for severe symptoms.
Allergic reaction (hazelnuts, milk, soya, gluten): Administer epinephrine if prescribed and seek emergency care immediately.
Dental injury (fractured tooth): Advise dental evaluation. Rinse mouth with warm water. Apply cold compress if swelling.

3. FIRE FIGHTING MEASURES

Flammability: Fat‑ and sugar‑based; flammable if exposed to open flame. Hazelnut oils intensify burning.
Extinguishing Media: Use foam, dry chemical, or CO₂. Do not use water.
Fire Response: For small fires, smother or use extinguisher. Evacuate for larger fires.